Minimally Invasive Total Versus Supracervical.3
Minimally Invasive Total Versus Supracervical.3
ORIGINAL RESEARCH n
Downloaded from by 160JIrZupeKnVeY0Mhusi94Erf3tG6nz94l7FPJgYcE/XurybG9lcuC0WTcruAFBGr2gi+FarLy9LXqm
hypothesizing that LSCH would demonstrate a higher proportion of Catherine A. Matthews, MDk
recurrent prolapse, but a lower proportion of mesh exposures.
Study Design This was a retrospective, secondary analysis comparing a Author affiliations, Conflicts of Interest, and
article information are provided at the end of
prospective cohort of patients undergoing TLH sacrocolpopexy versus a this article.
retrospective cohort of patients who had undergone LSCH sacrocolpopexy.
Our primary outcome was composite anatomic pelvic organ prolapse
recurrence (prolapse beyond hymen, apical descent > half vaginal length,
retreatment). Secondary outcomes included vaginal mesh exposures.
WHY THIS MATTERS
Results There were 733 procedures: 184 (25.1%) TLH sacrocolpopexy
The results of this study suggest
and 549 (74.9%) LSCH sacrocolpopexy. Median follow-up was longer in the
that total laparoscopic and lapa-
TLH cohort (369 [IQR 354–386] vs 190 [IQR 63–362] days, P < 0.01). roscopic supracervical hysterec-
There was no difference in composite prolapse recurrence between groups tomies are both acceptable
on bivariable analysis (3.3% vs 4.7%, P = 0.40). However, multivariable methods of concomitant hyster-
ectomy at the time of minimally
logistic regression demonstrated that TLH sacrocolpopexy had lower odds invasive sacrocolpopexy for
of composite pelvic organ prolapse recurrence than LSCH sacrocolpopexy uterovaginal prolapse, albeit with
(OR 0.21, 95% CI 0.05–0.82, P = 0.02). Among procedures with likely different risk profiles. Al-
though this study has certain limi-
lightweight mesh types, TLH demonstrated a higher proportion of mesh
tations, the current data represent
exposures compared to LSCH (10 [5.4%] vs 4 [1.1%], P < 0.01); however, one of the largest comparative
this was not significant after controlling for confounders (OR 4.51, 95% CI cohort studies addressing these
0.88–39.25, P = 0.08). There were no differences in retreatment clinical questions and add con-
temporary data to the existing lit-
or reoperation.
erature surrounding this topic.
Conclusion For the treatment of uterovaginal prolapse, both TLH and LSCH Surgeons can use the information
are acceptable methods of concomitant hysterectomy at the time of presented herein to guide surgi-
minimally invasive sacrocolpopexy, albeit with likely different risk profiles. cal decision making as well as
patient counseling regarding the
Urogynecology 2024;30:814–820 relative risk versus benefit ratio of
DOI: 10.1097/SPV.0000000000001530 total versus supracervical hyster-
ectomy at the time of minimally
invasive sacrocolpopexy.
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.
Sacrocolpopexy and Type of Hysterectomy
ORIGINAL RESEARCH n
or reoperation rates.5 Sacrocolpopexy with synthetic epithelium.”10 Secondary aims included objective pro-
mesh, however, confers unique risks of mesh-related lapse recurrence beyond the vaginal introitus,
complications,6 which may influence patient decision retreatment with a pessary or surgery, and a bother-
making. some bulge that could be seen or felt per the Pelvic
The specific method of hysterectomy likely affects Floor Distress Inventory-20 question 3.11 Given that
Downloaded from by 160JIrZupeKnVeY0Mhusi94Erf3tG6nz94l7FPJgYcE/XurybG9lcuC0WTcruAFBGr2gi+FarLy9LXqm
the risk versus efficacy ratio when performed at the the comparative retrospective dataset described as fol-
time of minimally invasive sacrocolpopexy (MISC). lows did not include patient-reported outcomes, these
Laparoscopic supracervical hysterectomy (LSCH) has were not assessed in the present study.
been associated with a lower risk of vaginal mesh ex- The second dataset was from a retrospective cohort
posure than total laparoscopic hysterectomy (TLH).7,8 of conventional or robot-assisted LSCH MISC per-
However, leaving the cervix in situ may increase the formed at a large academic medical center by Giugale
risk of recurrence. Limited data from a retrospective et al between 2009 and 2019 by 13 board-certified
cohort study of 83 women demonstrated an increased urogynecologists.3 This dataset comprised the LSCH
risk of recurrence in the anterior compartment in MISC cohort. Chart review was performed to obtain all
women undergoing LSCH as opposed to TLH.9 demographic, procedural, and postoperative data as
VTKFcA== on 09/28/2024
To expand upon the limited data available, we documented in the medical record. All women who
sought to compare postoperative outcomes between underwent laparoscopic or robot-assisted LSCH MISC
TLH and LSCH at the time of MISC for uterovaginal over the aforementioned time frame and had a docu-
POP from 2 independent, preexisting datasets. We hy- mented postoperative Pelvic Organ Prolapse Quantifi-
pothesized that LSCH MISC would demonstrate a cation (POP-Q)12 examination were included in this
higher proportion of recurrent POP but a lower pro- dataset. We excluded patients who had undergone a
portion of mesh exposures than TLH MISC. prior apical suspension procedure or prior hysterec-
tomy. At our institution, after the supracervical hys-
terectomy is performed, surgeons typically attach the
STUDY DESIGN mesh to the vagina with delayed absorbable monofila-
We performed a retrospective, secondary analysis of 2 ment sutures. We recommend yearly examinations af-
preexisting datasets from different institutions. Our ter mesh prolapse repair. However, patients often
goal was to compare outcomes after minimally invasive choose to follow up as needed and, thus, follow-up time
total hysterectomy with sacrocolpopexy to was variable. For the current study, we limited the ret-
supracervical hysterectomy with sacrocolpopexy for rospective cohort to 2 years of follow-up; we excluded
the primary treatment of uterovaginal POP. The patients with follow-up beyond 2 years to make the
datasets were chosen for convenience purposes, as the maximum duration of follow-up comparable between
data had previously been collected as part of prior hysterectomy groups. Choosing this follow-up time
studies. The first dataset comprising the TLH MISC limited to 2 years for the retrospective cohort resulted
cohort was from a prospective, multicenter, random- in a median follow-up time that most closely approxi-
ized controlled trial of TLH MISC by Matthews et al mated the 1-year follow-up of the prospective cohort.
that enrolled women from 2015 to 2019 by 8 board- Our primary outcome was composite anatomic
certified urogynecologists. This study compared vagi- POP recurrence, which was defined as any prolapse
nal mesh or permanent suture exposure rates in women beyond the hymen, apical descent greater than half of
undergoing conventional or robotic-assisted TLH the total vaginal length, or retreatment with either pes-
MISC with a lightweight polypropylene y-mesh sary or surgery. Secondary outcomes included intra-
(25 g/m2) using permanent versus delayed absorbable operative complications, operative time, estimated
monofilament sutures.7 Concomitant procedures were blood loss, anatomic compartment of recurrent POP,
permitted and performed per surgeon preference. mesh complications, and reoperations for either pro-
Method of vaginal cuff closure was performed per the lapse recurrence or mesh complications. Intraoperative
surgeons' preference and could have included complications included bladder injury, ureteral injury,
interrupted or continuous sutures with barbed, mono- bowel injury, blood transfusion, and vascular injury.
filament or braided absorbable suture material.7 Pa- Bladder injuries related to the hysterectomy or
tients were objectively evaluated at 6 weeks and 1 year sacrocolpopexy were included; midurethral sling trocar
after the procedure. Mesh exposure was defined as injuries were not included as a bladder injury for the
“vaginal mesh visualized through separated vaginal present study. Operative time was defined as procedure
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.
n ORIGINAL RESEARCH Sacrocolpopexy and Type of Hysterectomy
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.
Sacrocolpopexy and Type of Hysterectomy
ORIGINAL RESEARCH n
TABLE 2. Primary and Secondary Outcomes (n = 733) use of Y-mesh types of varying mesh densities: mesh
Total Laparoscopic weighing 19 g/m2 (n = 322, 58.8%), mesh weighing
Laparoscopic Supracervical 42 g/m2 (n = 188, 34.3%), and other lightweight mesh
Hysterectomy Hysterectomy types ≤25 g/m2 (n = 38, 6.9%) ( P < 0.001).
Sacrocolpopexy Sacrocolpopexy
P For the primary outcome of composite anatomic
Downloaded from by 160JIrZupeKnVeY0Mhusi94Erf3tG6nz94l7FPJgYcE/XurybG9lcuC0WTcruAFBGr2gi+FarLy9LXqm
Retreatment for 0.21, 95% CI 0.05–0.82, P = 0.02; Table 3). There was
recurrent prolapse
no difference in the specific anatomic compartment of
Surgery 1 (0.6%) 7 (1.3%) 0.69
POP recurrence or in retreatment for POP recurrence
Pessary 1 (0.6%) 5 (0.9%) 1.00
between TLH and LSCH MISC. A post-hoc power
Mesh exposure‡ 10 (5.4%) 4 (1.1%) <0.01
calculation for composite anatomic POP recurrence
Reoperation for mesh 2 (1.1%) 3 (0.8%) 1.00 revealed that we were underpowered to detect a differ-
exposure‡
ence between groups on uncontrolled analysis (with an
Any reoperation (for 3 (1.6%) 9 (2.5%) 0.76
prolapse recurrence estimated sample size of more than 2,000 patients
or mesh exposure)‡ needed per group). However, as noted, regression
Estimated blood 75 (50–100) 40 (30–60) <0.01 analysis demonstrated a significant association after
loss (mL) controlling for confounders.
Intraoperative For secondary outcomes, the TLH MISC cohort had
complications
longer mean operative time on bivariable analysis
Bladder injury 4 (2.2%) 1 (0.2%) 0.02
(216 ± 68 vs 194 ± 63 minutes, P < 0.01; Table 1). On
Ureteral injury 1 (0.5%) 0 (0%) 0.27
multivariable linear regression controlling for robotic
Bowel injury 1 (0.5%) 1 (0.2%) 0.46
versus laparoscopic surgical modality and concomitant
Data presented as n (%), mean (±SD), or median (interquartile range).
procedures, LSCH MISC remained significantly asso-
*Defined as prolapse beyond the hymen.
†Defined as apical descent > half of total vaginal length.
ciated with a shorter procedure time (β −17.9 minutes,
‡Subanalysis excluded n = 188 from supracervical hysterectomy group with
mesh type >25 g/m2.
TABLE 3. Multivariable Logistic Regression for Composite
Anatomic Prolapse Recurrence (n = 733)
POP-Q points were similar between groups; however,
Odds 95% Confidence
the TLH group had greater proportions of stage 2 and
Variable Ratio Interval P
stage 4 prolapse and a lower proportion of stage 3 pro-
Total hysterectomy 0.21 0.05–0.82 0.02
lapse than the LSCH group (Table 1). Additionally, the (reference: supracervical)
TLH group had significantly longer median follow-up Baseline POP-Q stage
than the LSCH group (369 [IQR 354–386] vs 190 [IQR (reference: stage 3)
63–362] days, P < 0.01). Stage 2 0.86 0.33–2.22 0.27
There were also important operative differences be- Stage 4 2.36 0.71–7.85 0.13
tween groups. The TLH cohort had higher proportions Laparoscopic approach 0.48 0.22–1.07 0.07
of robot-assisted procedures, (75.6% vs 45.2%) and (reference: robotic)
concomitant procedures, including posterior repair, Posterior repair 0.42 0.12–1.54 0.19
perineorrhaphy, and midurethral sling (Table 1). Addi- Perineorrhaphy 0.99 0.27–3.63 0.99
tionally, because of the study design, all of the TLH Midurethral sling 0.77 0.23–2.62 0.68
MISCs (n = 184, 100%) involved use of a Y-mesh with a Follow-up (d) 1.003 1.001–1.005 <0.01
mesh density of 25 g/m2. However, the LSCHs involved POP-Q, Pelvic Organ Prolapse Quantification.
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.
n ORIGINAL RESEARCH Sacrocolpopexy and Type of Hysterectomy
95% CI −31.12 to −4.73, P < 0.01) (Supplemental Ta- TLH at the time of MISC was associated with a
ble, http://links.lww.com/FPMRS/A509). decreased odds of composite anatomic POP recurrence
The TLH MISC cohort demonstrated a significantly compared to LSCH MISC. Although there were more
greater proportion of bladder injury compared to the vaginal mesh exposures in the TLH group, TLH was
LSCH MISC cohort (2.2% vs 0.2%, P = 0.02). There not an independent risk factor for mesh exposure af-
Downloaded from by 160JIrZupeKnVeY0Mhusi94Erf3tG6nz94l7FPJgYcE/XurybG9lcuC0WTcruAFBGr2gi+FarLy9LXqm
were no differences in ureteral or bowel injury. There ter controlling for potential confounding variables.
was a statistically higher estimated blood loss in the Notably, the overall number of POP recurrence and
TLH group, although this likely does not represent mesh exposures were low. Both TLH and LSCH at the
clinical significance (Table 2). time of MISC were associated with low POP recurrence
For analysis and comparison of mesh complications, and low risk of mesh exposure within 1 year of surgery.
we included only mesh types with a density ≤25 g/m2 Our results suggest that TLH and LSCH are both ac-
(n = 545). There were a total of 14 (2.6%) vaginal mesh ceptable methods of concomitant hysterectomy at the
exposures. The TLH MISC cohort demonstrated a time of MISC for uterovaginal prolapse, albeit with
higher proportion of mesh exposure compared to the likely different risk profiles. Surgeons can use these data
LSCH MISC cohort (5.4% [n = 10] vs 1.1% [n = 4]; to inform surgical decision making as well as patient
VTKFcA== on 09/28/2024
P < 0.01). However, on multivariable logistic regres- counseling regarding the relative risk versus benefit ra-
sion, TLH MISC was not an independent risk factor for tio of TLH versus LSCH at the time of MISC.
mesh exposure when adjusting for smoking, surgical We demonstrate an association between LSCH
modality, and follow-up time (OR 4.51, 95% CI MISC and composite anatomic prolapse recurrence
0.88–39.25, P = 0.08) (Table 4). A post-hoc power after controlling for other factors that may affect pro-
calculation revealed that we were adequately powered lapse recurrence. Our results are consistent with the
at 85% to detect a difference in mesh complications limited previously published data on this topic. In a
between groups on bivariable analysis. Reoperation for small retrospective cohort study of 83 women, Myers
mesh exposure was similar between groups (Table 2). et al demonstrated a 2.8-fold increased risk of prolapse
Vaginal mesh exposure was the only mesh complication recurrence in the anterior compartment in women un-
noted within the 2 cohorts without any cases of mesh dergoing LSCH as opposed to TLH MISC.9 Although
complications involving other viscera. When we com- theoretical, it is possible that leaving the cervix in situ
bined reoperations for either prolapse recurrence or decreases the length of dissection along the anterior
mesh exposure, there was no difference in the propor- vaginal wall, limiting a surgeon's ability to suspend the
tion of total reoperations between hysterectomy groups entire anterior vaginal wall effectively and potentially
(Table 2). also affecting mesh tensioning. Another possible ex-
planation is that TLH results in a shorter anterior vag-
inal wall compared to LSCH MISC. However, given
DISCUSSION that short-term retreatment and reoperation rates were
In this large, retrospective, multicenter comparison of similar between hysterectomy groups, the clinical sig-
women undergoing MISC for uterovaginal prolapse, nificance of increased anatomic prolapse recurrence in
the LSCH MISC group is unknown. It should be noted
that, although the LSCH cohort did have a proportion
TABLE 4. Multivariable Logistic Regression for Mesh of MISC performed using higher mesh densities, we do
Exposure (n = 545) not anticipate this would have affected our prolapse
Exact 95% recurrence outcomes based on recent data demonstrat-
Odds Confidence
Variable Ratio Interval P
ing no difference in overall composite prolapse recur-
Total laparoscopic hysterectomy 4.52 0.88–39.25 0.08
rence between mesh types of different densities.13
(reference: supracervical) Although there were significantly more mesh expo-
Smoking status (reference: current) sures in the TLH group on bivariable analysis, TLH
Never 0.12 0.01–1.51 0.08 was not an independent risk factor for mesh exposure
Former 0.14 0.01–2.16 0.10 compared to LSCH after adjusting for potential con-
Laparoscopic approach 0.19 0.004–1.37 0.14 founders. For many years, data regarding mesh expo-
Follow-up 1.00 0.99–1.01 0.83 sure rates after LSCH versus TLH MISC have been
Subanalysis excluded n = 188 from supracervical hysterectomy group with mesh
conflicting. A recent systematic review and meta-
type >25 g/m2. analysis of 19 observational studies, which included
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.
Sacrocolpopexy and Type of Hysterectomy
ORIGINAL RESEARCH n
tomy vs laparoscopic supracervical hysterectomy) at the up was limited; however, and it is plausible that
time of minimally invasive sacrocolpopexy for reoperations for recurrent prolapse will increase over
uterovaginal prolapse. We compared a prospective co-
time. Although we demonstrate a statistically signifi-
hort of patients undergoing total laparoscopic hysterec-
tomy to a retrospective cohort of patients who had un- cant decrease in composite anatomic prolapse with
dergone laparoscopic supracervical hysterectomy per- TLH MISC, there was a trend toward more mesh ex-
formed at the time of minimally invasive sacrocolpopexy. posures in this group. Prior research has demonstrated
We demonstrate that, regardless of the type of hyster- that perceptions of complications and outcomes differ
ectomy performed, both procedures were associated significantly between patients and surgeons14; thus,
with low risks of pelvic organ prolapse recurrence and
understanding patient-centered outcomes and the clin-
vaginal mesh exposures within 1 year of surgery. Total
ical meaningfulness of these findings would aid in our
VTKFcA== on 09/28/2024
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.
n ORIGINAL RESEARCH Sacrocolpopexy and Type of Hysterectomy
longer median follow-up in the TLH group because of 3. Giugale LE, Melnyk AI, Ruppert KM, et al. Total vaginal hysterectomy
with uterosacral ligament suspension compared with supracervical
the prospective study design). Our results may underes- hysterectomy with sacrocervicopexy for uterovaginal prolapse. Obstet
timate POP recurrence and mesh complications given Gynecol. 2021;138(3):435–442. doi:10.1097/AOG.
that these outcomes can increase over time. We took 0000000000004484.
multiple steps to account for unequal follow-up time, 4. Nygaard I, Brubaker L, Zyczynski HM, et al. Long-term outcomes
Downloaded from by 160JIrZupeKnVeY0Mhusi94Erf3tG6nz94l7FPJgYcE/XurybG9lcuC0WTcruAFBGr2gi+FarLy9LXqm
© 2024 American Urogynecologic Society. All rights reserved. 14. Fitzgerald J, Richter HE, Sung V, et al. Development of a simplified
patient-centered pelvic floor surgery complication scale. Female Pelvic
Med Reconstr Surg. 2022;28(4):233–239. doi:10.1097/SPV.
0000000000001099.
REFERENCES 15. Das D, Carroll A, Mueller M, et al. Mesh complications after total vs
1. Siddiqui NY, Grimes CL, Casiano ER, et al. Mesh sacrocolpopexy supracervical laparoscopic hysterectomy at time of minimally invasive
compared with native tissue vaginal repair: a systematic review and sacrocolpopexy. Int Urogynecol J. 2022;33(9):2507–2514. doi:10.
meta-analysis. Obstet Gynecol. 2015;125(1):44–55. doi:10.1097/ 1007/s00192-022-05251-0.
AOG.0000000000000570. 16. Dallas K, Taich L, Kuhlmann P, et al. Supracervical hysterectomy is
2. Wang LC, Al Hussein Al Awamlh B, Hu JC, et al. Trends in mesh protective against mesh complications after minimally invasive
use for pelvic organ prolapse repair from the Medicare database. abdominal sacrocolpopexy: a population-based cohort study of 12,189
Urology. 2015;86(5):885–891. doi:10.1016/j.urology.2015. patients. J Urol. 2022;207(3):669–676. doi:10.1097/JU.
08.022. 0000000000002262.
Copyright © 2024 American Urogynecologic Society. Unauthorized reproduction of this article is prohibited.